Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Asahina, H, Yamazaki, K, Kinoshita, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359984/
http://dx.doi.org/10.1038/sj.bjc.6603565
_version_ 1782152935231193088
author Asahina, H
Yamazaki, K
Kinoshita, I
author_facet Asahina, H
Yamazaki, K
Kinoshita, I
author_sort Asahina, H
collection PubMed
description
format Text
id pubmed-2359984
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23599842009-09-10 Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer Asahina, H Yamazaki, K Kinoshita, I Br J Cancer Letter to the Editor Nature Publishing Group 2007-01-29 2007-01-09 /pmc/articles/PMC2359984/ http://dx.doi.org/10.1038/sj.bjc.6603565 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Asahina, H
Yamazaki, K
Kinoshita, I
Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer
title Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer
title_full Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer
title_fullStr Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer
title_full_unstemmed Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer
title_short Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer
title_sort reply: appropriate prospective trials are warranted to determine differences between exon 19 deletions and l858r egfr mutations in non-small cell lung cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359984/
http://dx.doi.org/10.1038/sj.bjc.6603565
work_keys_str_mv AT asahinah replyappropriateprospectivetrialsarewarrantedtodeterminedifferencesbetweenexon19deletionsandl858regfrmutationsinnonsmallcelllungcancer
AT yamazakik replyappropriateprospectivetrialsarewarrantedtodeterminedifferencesbetweenexon19deletionsandl858regfrmutationsinnonsmallcelllungcancer
AT kinoshitai replyappropriateprospectivetrialsarewarrantedtodeterminedifferencesbetweenexon19deletionsandl858regfrmutationsinnonsmallcelllungcancer

Ejemplares similares